CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- DEF 14A Proxy Proxy Statement
- 144 Insider Sale of Securities
- 4 Planned sale CHIEF OPERATING OFFICER sold 12,000 shares at an average $20.48 ($245,812)
- 144 Insider Sale of Securities
- PRE 14A Proxy Proxy Statement (Preliminary)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 801 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 1,303 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 4,832 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 734 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 727 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 1,666 shares (to pay taxes)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 984 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 991 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 1,617 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF OPERATING OFFICER gave up 1,034 shares (to pay taxes)
- 4 Shares withheld for taxes CHAIRMAN & CEO gave up 5,321 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF ACCOUNTING OFFICER gave up 2,084 shares (to pay taxes)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 15,944 shares at $23.11 ($368,466)
- 4 Planned sale CHIEF FINANCIAL OFFICER sold 20,343 shares at $23.10 ($469,923)
Page 12 of 39 · 778 filings